Your shopping cart is currently empty

AzddMeC (Az-Dcme) is a nucleoside analog with antiviral activity and is an orally active and selective inhibitor of HIV-1 reverse transcriptase and HIV-1 replication.AzddMeC has an EC50 value of 9 nM against HIV-1-infected human PBM cells and 6 nM against HIV-1-infected human macrophages.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $43 | In Stock | In Stock | |
| 5 mg | $103 | In Stock | In Stock | |
| 10 mg | $167 | In Stock | In Stock | |
| 25 mg | $337 | In Stock | In Stock | |
| 50 mg | $535 | In Stock | In Stock | |
| 100 mg | $893 | In Stock | In Stock |
| Description | AzddMeC (Az-Dcme) is a nucleoside analog with antiviral activity and is an orally active and selective inhibitor of HIV-1 reverse transcriptase and HIV-1 replication.AzddMeC has an EC50 value of 9 nM against HIV-1-infected human PBM cells and 6 nM against HIV-1-infected human macrophages. |
| Targets&IC50 | HIV-1:6 nM (EC50, Human macrophages), HIV-1:9 nM (EC50, Human PBM cells) |
| In vitro | AzddMeC emerged as the most potent inhibitor of hepatitis B virus DNA polymerase (50% inhibitor dose, 0.03-0.35 μM). In contrast, cellular DNA polymerase was shown to be resistant to or partially (β) affected by AzddMeC. [4] |
| In vivo | Following intravenously and orally administered 60 mg/kg AzddMeC to male rhesus monkeys, 3'-azido-3'-deoxythymidine (AZT) was found to be the major metabolite of AzddMeC in monkeys. Serum concentrations of AzddMeC decreased rapidly in a biexponential manner with terminal half-lives ranging from 0.5 to 1.3 h. Total clearance of AzddMeC was 2.00 +/- 0.41 l/h/kg (mean +/- standard deviation) and the fraction of AzddMeC metabolized to AZT was 0.32 +/- 0.05. The total clearance was 2.00 +/- 0.41 l/h/kg (mean +/- standard deviation).[2] |
| Synonyms | CS-92, Azidodideoxymethylcytidine, Az-Dcme |
| Molecular Weight | 266.26 |
| Formula | C10H14N6O3 |
| Cas No. | 87190-79-2 |
| Smiles | Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)nc1N |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (375.57 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.